• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER, INC. (JUAREZ) NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER, INC. (JUAREZ) NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number D-1266-01-S
Device Problem Insufficient Information (3190)
Patient Problems Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226)
Event Date 04/19/2017
Event Type  Injury  
Manufacturer Narrative
Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.As such, the investigation will be closed.If the complaint device is received in the future, we will reopen the complaint and perform the investigation as appropriate.The device history record (dhr) was reviewed and no anomalies were found related to this complaint.In addition, the dhr review verifies that the device was manufactured in accordance with documented specification and procedures.Concomitant products: carto 3 system, model # m-4800-01, s/n: (b)(4).St.Jude medical brk transseptal needle.St.Jude medical sl0 8.5fr sheath.(b)(4).
 
Event Description
It was reported that a (b)(6) male patient underwent a pulmonary vein isolation (pvi) ablation procedure for paroxysmal atrial fibrillation with a navistar thermocool catheter and suffered a cardiac tamponade requiring pericardiocentesis.While ablating around the left pulmonary veins, the patient became hypotensive and a tamponade was confirmed via intracardiac echocardiogram.Pericardiocentesis yielded 800 ml.Remainder of procedure was aborted.Patient was reported to be in stable condition immediately after the intervention.Patient required extended hospitalization (1 day) as a result of the adverse event.Patient fully recovered.Patient was in sinus rhythm during the procedure.Factors cited that may have contributed to the adverse event included a slightly difficult transseptal puncture.Physician did not provide a causality opinion.It was noted that the physician does not believe a bwi product was responsible for the injury.Transseptal puncture was performed with a st.Jude medical brk transseptal needle and a st.Jude medical sl0 8.5 french sheath.Generator parameters and settings at the time of injury were not reported, as the event was not directly related to a specific ablation site.Power was not titrated during ablation.Overall ablation time and last ablation cycle time at the site of injury were not reported, as the site of injury is unknown.Irrigated catheter flow was set at 30 ml/min.Patient received anticoagulant during the procedure with activated clotting time (act) maintained between 300-350 seconds.Act was 330 seconds at the time of injury.There were no errors reported on any bwi equipment during the procedure.
 
Manufacturer Narrative
On 6/8/2017, the bwi failure analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.(b)(4).
 
Manufacturer Narrative
(b)(4) it was reported that a (b)(6) male patient underwent a pulmonary vein isolation (pvi) ablation procedure for paroxysmal atrial fibrillation with a navistar thermocool catheter and suffered a cardiac tamponade requiring pericardiocentesis.The returned device was visually inspected, and it was found in good condition.The catheter was evaluated for carto 3 system performance, and was recognized by the system with no error messages and proper visualization.Eeprom data demonstrates that the catheter was properly calibrated during manufacturing.The catheter was tested for electrical performance and stockert compatibility, and was found within specifications.Deflection and irrigation tests were performed, which the catheter passed.The device history record (dhr) was reviewed, and no anomalies were found related to this complaint.In addition, the dhr review verifies that the device was manufactured in accordance with documented specification and procedures.The catheter passed all specifications.The root cause of the cardiac tamponade remains unknown.The instructions for use state that careful catheter manipulation must be performed in order to avoid cardiac damage, perforation or tamponade.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BIOSENSE WEBSTER, INC. (JUAREZ)
circuito interior norte #1820
parque industrial salvacar
juarez, chihuahua 32599
MX  32599
Manufacturer (Section G)
BIOSENSE WEBSTER, INC. (JUAREZ)
circuito interior norte #1820
parque industrial salvacar
juarez, chihuahua 32599
MX   32599
Manufacturer Contact
joaquin kurz
33 technology drive
irvine, CA 92618
9497893837
MDR Report Key6557098
MDR Text Key74829534
Report Number9673241-2017-00369
Device Sequence Number1
Product Code OAD
UDI-Device Identifier10846835008500
UDI-Public(01)10846835008500(11)170126(17)191231(10)17634731M
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 04/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2019
Device Model NumberD-1266-01-S
Device Catalogue NumberNR7TCSIY
Device Lot Number17634731M
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/08/2017
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/19/2017
Initial Date FDA Received05/10/2017
Supplement Dates Manufacturer ReceivedNot provided
04/19/2017
Supplement Dates FDA Received06/12/2017
07/20/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/26/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age63 YR
-
-